The in vitro diagnostics (ivd) quality control global market report 2024 from The Business Research Company provides comprehensive market statistics, including global market size, regional shares, competitor market share, detailed segments, trends, and opportunities. This report offers an in-depth analysis of current and future industry scenarios, delivering a complete perspective for thriving in the industrial automation software market.
In Vitro Diagnostics IVD Quality Control Market, 2024 report by The Business Research Company offers comprehensive insights into the current state of the market and highlights future growth opportunities.
Market Size –
The in vitro diagnostics (ivd) quality control market size has grown strongly in recent years. It will grow from $1.33 billion in 2023 to $1.42 billion in 2024 at a compound annual growth rate (CAGR) of 6.8%. The growth in the historic period can be attributed to regulatory compliance, increasing prevalence of diseases, growing aging population, expansion of diagnostic laboratories, increased awareness and demand for precision medicine.
The in vitro diagnostics (ivd) quality control market size is expected to see strong growth in the next few years. It will grow to $1.91 billion in 2028 at a compound annual growth rate (CAGR) of 7.8%. The growth in the forecast period can be attributed to personalized medicine advancements, point-of-care testing expansion, digital health integration, adoption of next-generation sequencing (ngs, global health security concerns, integration with electronic health records (ehr): . Major trends in the forecast period include multi-analyte quality control materials, ai and machine learning applications, on-demand quality control solutions, continuous monitoring and real-time feedback, portable and easy-to-use quality control devices.
Order your report now for swift delivery @
https://www.thebusinessresearchcompany.com/report/in-vitro-diagnostics-ivd-quality-control-global-market-report
Scope Of In Vitro Diagnostics IVD Quality Control Market
The Business Research Company’s reports encompass a wide range of information, including:
1. Market Size (Historic and Forecast): Analysis of the market’s historical performance and projections for future growth.
2. Drivers: Examination of the key factors propelling market growth.
3. Trends: Identification of emerging trends and patterns shaping the market landscape.
4. Key Segments: Breakdown of the market into its primary segments and their respective performance.
5. Focus Regions and Geographies: Insight into the most critical regions and geographical areas influencing the market.
6. Macro Economic Factors: Assessment of broader economic elements impacting the market.
Market Drivers –
The rise in the prevalence of infectious diseases such as HIV and cancer is significantly contributing to the growth of the in vitro diagnostics quality control market. Infectious diseases are common and caused by the transmission of pathogens such as viruses, bacteria, fungi, or parasites. The rise in infectious diseases, including HIV and cancer cases, necessitates novel diagnostic testing goods and services for effective treatment, which is driving up demand for in vitro diagnostics quality control that ensures the accuracy, performance, and quality of test equipment and findings. For instance, according to the Office for National Statistics, a UK-based recognized national statistics institute, in England at the end of the week ending December 9, 2022, the infection rate climbed for people aged 35 to 69 years and increased for those in school years 12 to 24 years. Therefore, the rise in the prevalence of infectious diseases such as HIV and cancer is expected to drive the growth of the in-vitro diagnostics quality control market over the forecast years.
Market Trends –
Product innovations have emerged as the key trend gaining popularity in the 5G chipset market. The major players in the market are developing innovative products for market growth. For instance, in June 2021, Samsung Electronics, a South Korea-based electronics company, developed 3GPP Rel.16 compliant chipsets, a range of next-generation 5G chipsets that deliver cutting-edge 5G technologies. The new chipsets consist of a second-generation 5G modem System-on-Chip (SoC), a third-generation mmWave Radio Frequency Integrated Circuit (RFIC) chip, and a Digital Front End (DFE)-RFIC integrated chip. These are designed to increase power efficiency, boost performance, and reduce the size of 5G solutions.
The in vitro diagnostics (ivd) quality control market covered in this report is segmented –
1) By Product type: Quality Control Products, Data Management Solutions, Quality Assurance Services
2) By Manufacturer Type: IVD Instrument Manufacturers, Third Party Quality Control Manufacturers
3) By Application: Clinical Chemistry, Hematology, Immunoassay, Molecular Diagnostics, Microbiology, Coagulation Or Hemostasis, Other Applications
4) By End-Users: Hospitals, Clinical Laboratories, Research And Academic Institutes, Other End Users
Get an inside scoop of the in vitro diagnostics ivd quality control market, Request now for Sample Report @
https://www.thebusinessresearchcompany.com/sample_request?id=5559&type=smp
Regional Insights –
North America was the largest region in the in vitro diagnostics (IVD) quality control market in 2023. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the in vitro diagnostics (ivd) quality control market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa
Key Companies –
Major companies operating in the in vitro diagnostics (ivd) quality control market report are Bio-Rad Laboratories Inc., Thermo Fisher Scientific Inc., LGC Limited., Abbott Laboratories, Roche Diagnostics AG, Siemens AG, Ortho Clinical Diagnostics Inc., Helena Laboratories Corporation, Quidel Corporation, Microbiologics Inc., Sun Diagnostics LLC, SeraCare Life Sciences Inc., Fortress Diagnostics Ltd., Seegene Inc., Bio-Techne Corp., Randox Laboratories, Danaher Corporation, Sysmex Corporation, Beckman Coulter Inc., Grifols India Healthcare Private Limited., Hologic Inc., Qiagen NV, Becton Dickinson and Company, Luminex Corporation, BioMerieux SA, Meridian Bioscience Inc., Sekisui Diagnostics LLC, ZeptoMetrix Corporation, Maine Molecular Quality Controls Inc., Maine Standards Company LLC
Table of Contents
1. Executive Summary
2. In Vitro Diagnostics IVD Quality Control Market characterstics
3. In Vitro Diagnostics IVD Quality Control Market Trends And Strategies
4. In Vitro Diagnostics IVD Quality Control Market – Macro Economic Scenario
5. Global In Vitro Diagnostics IVD Quality Control Market Size And Growth
.
.
.
31. Global In Vitro Diagnostics (IVD) Quality Control Market Competitive Benchmarking
32. Global In Vitro Diagnostics (IVD) Quality Control Market Competitive Dashboard
33. Key Mergers And Acquisitions In The In Vitro Diagnostics (IVD) Quality Control Market
34. In Vitro Diagnostics (IVD) Quality Control Market Future Outlook and Potential Analysis
35. Appendix
Contact Us:
The Business Research Company
Europe: +44 207 1930 708
Asia: +91 88972 63534
Americas: +1 315 623 0293
Email: [email protected]
Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
Twitter: https://twitter.com/tbrc_info
Facebook: https://www.facebook.com/TheBusinessResearchCompany
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Blog: https://blog.tbrc.info/
Healthcare Blog: https://healthcareresearchreports.com/
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
